C20H16N2O4
Neat
348.35
Topotecan Related Compound C
-20°C
Frozen (-20°C)
1H-Pyrano[3, 4:6, 7]indolizino[1, 2-b]quinoline-3, 14(4H, 12H)-dione, 4-ethyl-4-hydroxy-, (4S)-, 1H-Pyrano[3, 4:6, 7]indolizino[1, 2-b]quinoline-3, 14(4H, 12H)-dione, 4-ethyl-4-hydroxy-, (S)-, Camptothecine (7CI), (+)-Camptothecin, (+)-Camptothecine, (4S)-4-Ethyl-4-hydroxy-1H-pyrano[3, 4:6, 7]indolizino[1, 2-b]quinoline-3, 14(4H, 12H)-dione, (S)-(+)-Camptothecin, (S)-Camptothecin, 20(S)-Camptothecin, 20(S)-Camptothecine, Campathecin, Camptothecin, MAG-CPT, NSC 94600, S-CKD 602, d-Camptothecin, Topotecan related, SKF-S-104962, Topotecan Related Compound C, Irinotecan Hydrochloride Trihydrate Impurity D and Irinotecan Impurity D
CC[C@@]1(O)C(=O)OCC2=C1C=C3N(Cc4cc5ccccc5nc34)C2=O
(19S)-19-ethyl-19-hydroxy-17-oxa-3, 13-diazapentacyclo[11.8.0.02, 11.04, 9.015, 20]henicosa-1(21), 2, 4, 6, 8, 10, 15(20)-heptaene-14 and 18-dione